Home

láta af hendi eldur Kæri nmd pharma aps sjálfsmorð Ókostur Óbætanlegt

NMD Pharma, finalist i Life Sciences kategorien - EY Danmark
NMD Pharma, finalist i Life Sciences kategorien - EY Danmark

News — NMD Pharma
News — NMD Pharma

Management team — NMD Pharma
Management team — NMD Pharma

NMD Pharma - PIR International
NMD Pharma - PIR International

NMD Pharma company information, funding & investors | Dealroom.co
NMD Pharma company information, funding & investors | Dealroom.co

Nete Huus's email & phone | NMD Pharma ApS's Senior Scientist email
Nete Huus's email & phone | NMD Pharma ApS's Senior Scientist email

Aarhus-biotek tager kampen op mod neuromuskulære sygdomme - Business Review
Aarhus-biotek tager kampen op mod neuromuskulære sygdomme - Business Review

Aarhus-biotek tager kampen op mod neuromuskulære sygdomme - Business Review
Aarhus-biotek tager kampen op mod neuromuskulære sygdomme - Business Review

NMD Pharma - Crunchbase Company Profile & Funding
NMD Pharma - Crunchbase Company Profile & Funding

NMD Pharma A/S | LinkedIn
NMD Pharma A/S | LinkedIn

NMD Pharma A/S | Virksomhedsprofil og regnskaber | eStatistik
NMD Pharma A/S | Virksomhedsprofil og regnskaber | eStatistik

NMD Pharma ApS Annual Report for 1 January - 31 December 2017
NMD Pharma ApS Annual Report for 1 January - 31 December 2017

Katja Krustrup Pedersen - Research Scientist and Project Manager - NMD  Pharma | LinkedIn
Katja Krustrup Pedersen - Research Scientist and Project Manager - NMD Pharma | LinkedIn

NMD Pharma
NMD Pharma

NMD Pharma company information, funding & investors | Dealroom.co
NMD Pharma company information, funding & investors | Dealroom.co

Ulrik Sørensen – CEO – Ankrin Therapeutics | LinkedIn
Ulrik Sørensen – CEO – Ankrin Therapeutics | LinkedIn

NMD Pharma - Capnova
NMD Pharma - Capnova

Lars J. S. Knutsen - VP, Medicinal Chemistry - NMD Pharma ApS | LinkedIn
Lars J. S. Knutsen - VP, Medicinal Chemistry - NMD Pharma ApS | LinkedIn

Management team — NMD Pharma
Management team — NMD Pharma

WO2016202341A1 - Compounds for use in treating neuromuscular disorders -  Google Patents
WO2016202341A1 - Compounds for use in treating neuromuscular disorders - Google Patents

NMD Pharma ApS « Danish Science and The City DKBIO 17 « Solebury Trout  Access
NMD Pharma ApS « Danish Science and The City DKBIO 17 « Solebury Trout Access

About - InsuSense Therapeutics
About - InsuSense Therapeutics

Myasthenia Gravis R&D Pipeline Analysis Report, Q4 2020
Myasthenia Gravis R&D Pipeline Analysis Report, Q4 2020

NMD Pharma ApS « Danish Science and The City DKBIO 17 « Solebury Trout  Access
NMD Pharma ApS « Danish Science and The City DKBIO 17 « Solebury Trout Access

NMD Pharma
NMD Pharma

Nmd Pharma A/S, Aarhus N | firma | krak.dk
Nmd Pharma A/S, Aarhus N | firma | krak.dk

WO2016202341A1 - Compounds for use in treating neuromuscular disorders -  Google Patents
WO2016202341A1 - Compounds for use in treating neuromuscular disorders - Google Patents

Aarhus-biotek tager kampen op mod neuromuskulære sygdomme - Business Review
Aarhus-biotek tager kampen op mod neuromuskulære sygdomme - Business Review